Director, Commercial, Poland

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Commercial Lead Poland is responsible for defining and executing the local commercial strategy for RevMEd portfolio and launches. This role is accountable for building the commercial organization, driving launch and growth performance, and ensuring strong alignment across Medical Affairs, Market Access, and other key functions. The incumbent will proactively identify and address relevant systemic opportunities and barriers, including healthcare structures, competitor dynamics, data gaps, diagnostic challenges, and advocacy needs, as well as HCP-related opportunities such as therapeutic gaps, differentiation, economic value attributes, and clear communication of patient- and physician-relevant benefits. The Commercial Lead Poland will oversee the generation of insights from the therapeutic field and translate these insights into a comprehensive, cross-functional commercial strategy. In support of clear positioning and an aligned communication approach, the incumbent will also ensure the development and implementation of tactics and tools that enable the field force to effectively address customer needs. Responsibilities: Act as the commercial lead for Poland, accountable for local commercial strategy, execution, and performance across the oncology portfolio. Serve as a core member of the Poland Leadership Team, contributing to country strategy, launch planning, and key business decisions. Partner with regional and local Medical Affairs and Market Access teams to translate clinical and economic evidence into compelling value communications tailored to Poland stakeholders, including HCPs and payers. Translate regional and global commercial strategies into locally optimized plans aligned with Poland market dynamics, customer needs, and healthcare system requirements, in close collaboration with the European commercial team. Represent Poland in regional commercial discussions and contribute country insights to shape broader commercial plans and strategy. Develop and execute country-level brand and portfolio strategies across pre-launch, launch, and post-launch phases. Drive demand generation and appropriate use through non-promotional and promotional channels, in compliance with local regulations. Lead forecasting, budgeting, and operational planning for the country in close collaboration with the ED, Commercial Excellence, Business Analytics and Insights, Europe. Lead commercial launch readiness for oncology products, including customer strategy, segmentation, targeting, and field force planning. Partner closely with Medical Affairs and Market Access to ensure integrated launch execution and consistent external engagement. Monitor performance, competitive dynamics, and market trends, adjusting strategy and execution as needed. Oversee engagement strategy across key stakeholders, including oncologists, treatment centers, and healthcare organizations. Ensure effective field force deployment and capability building. Build, lead, and develop the country commercial organization, including sales, marketing, and customer-facing roles as the business scales. Establish commercial processes, governance, and ways of working as part of the country build-out. Foster a culture…